title: Recombinant species-specific growth hormone increases hard callus formation in distraction osteogenesis.
abstract: The effect of growth hormone (GH) on secondary fracture healing and callus formation has been demonstrated in several previously investigated animal models. The aim of this study was to investigate and quantify the effects of GH on bone regenerates in a distraction osteogenesis model. In 20 mature female Yucatan micropigs, the tibia and fibula were osteotomized, stabilized with an external fixator, and distracted at 2 mm/day for 10 days after a 4 day latency period. The regenerates were allowed to consolidate for 10 days. Micropigs in the study group (ten animals) received a daily injection of 100 microg per kilogram body weight of recombinant porcine growth hormone (r-pGH). Micropigs in the control group (ten animals) received sodium chloride as placebo. After killing on day 25, a quantitative histomorphometrical analysis of the formed callus and the adjacent cortical bone was performed and the results of polychrome in vivo labeling were assessed. The regenerates of the r-pGH-treated animals showed a significantly larger callus area but no change in callus structure. We found islands of cartilage tissue in the regenerates of both groups; the calli from the control group exhibited a higher fraction of cartilage compared with the r-pGH group, but this was not significant. Quantification of the fluorescent in vivo labeling revealed that the distraction gap in GH-treated group showed significant ossification even during distraction. These results demonstrate that growth hormone can accelerate the maturation of the regenerate in distraction osteogenesis without changing the callus microstructure. This may prove to be a useful clinical tool for shortening the healing time in limb lengthening and bone segment transport.
authors.affiliation: Department of Trauma and Reconstructive Surgery, Charité, University of Berlin, Berlin, Germany. hermann.bail@charite.de
authors.forename: H J
authors.initials: HJ
authors.lastname: Bail
authors.forename: M J
authors.initials: MJ
authors.lastname: Raschke
authors.forename: S
authors.initials: S
authors.lastname: Kolbeck
authors.forename: G
authors.initials: G
authors.lastname: Krummrey
authors.forename: H J
authors.initials: HJ
authors.lastname: Windhagen
authors.forename: A
authors.initials: A
authors.lastname: Weiler
authors.forename: K
authors.initials: K
authors.lastname: Raun
authors.forename: Li
authors.initials: L
authors.lastname: Mosekilde
authors.forename: N P
authors.initials: NP
authors.lastname: Haas
mesh_terms: D000818:Animals; D015519:Bone Density / Q000187:drug effects; D001861:Bone Regeneration / Q000187:drug effects*; D002146:Bony Callus / Q000187:drug effects* / Q000473:pathology; D002356:Cartilage / Q000187:drug effects / Q000473:pathology; D005260:Female; D013006:Growth Hormone / Q000494:pharmacology*; D010012:Osteogenesis / Q000187:drug effects*; D011994:Recombinant Proteins / Q000494:pharmacology; D013552:Swine; D013556:Swine, Miniature
chemical_list: D011994:Recombinant Proteins; D013006:Growth Hormone